These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 26444353)

  • 41. Clinical, biochemical and pathological predictors of poor response to intravenous cyclophosphamide in patients with proliferative lupus nephritis.
    Conlon PJ; Fischer CA; Levesque MC; Smith SR; St Clair EW; Allen NB; Fleming JA; Howell DN
    Clin Nephrol; 1996 Sep; 46(3):170-5. PubMed ID: 8879851
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical and immunological effects of Rituximab in patients with lupus nephritis refractory to conventional therapy: a pilot study.
    Vigna-Perez M; Hernández-Castro B; Paredes-Saharopulos O; Portales-Pérez D; Baranda L; Abud-Mendoza C; González-Amaro R
    Arthritis Res Ther; 2006; 8(3):R83. PubMed ID: 16677395
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Remission of lupus nephritis: the trajectory of histological response in successfully treated patients.
    Malvar A; Alberton V; Lococo B; Lourenco M; Martinez J; Burna L; Besso C; Navarro J; Nagaraja HN; Khatiwada A; Wolf B; Rovin B
    Lupus Sci Med; 2023 May; 10(1):. PubMed ID: 37258036
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Urinary markers differentially associate with kidney inflammatory activity and chronicity measures in patients with lupus nephritis.
    Akhgar A; Sinibaldi D; Zeng L; Farris AB; Cobb J; Battle M; Chain D; Cann JA; Illei GG; Lim SS; White WI
    Lupus Sci Med; 2023 Jan; 10(1):. PubMed ID: 36717181
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Predictive power of the second renal biopsy in lupus nephritis: significance of macrophages.
    Hill GS; Delahousse M; Nochy D; Rémy P; Mignon F; Méry JP; Bariéty J
    Kidney Int; 2001 Jan; 59(1):304-16. PubMed ID: 11135084
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Large variability of the activity and chronicity indexes within and between histological classes of lupus nephritis.
    Azoicăi T; Belibou IM; Lozneanu L; Giuşcă SE; Cojocaru E; Căruntu ID
    Rom J Morphol Embryol; 2017; 58(1):73-78. PubMed ID: 28523301
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lupus nephritis in Southern Chinese patients: clinicopathologic findings and long-term outcome.
    Mok CC; Wong RW; Lau CS
    Am J Kidney Dis; 1999 Aug; 34(2):315-23. PubMed ID: 10430980
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association of intrarenal B-cell infiltrates with clinical outcome in lupus nephritis: a study of 192 cases.
    Shen Y; Sun CY; Wu FX; Chen Y; Dai M; Yan YC; Yang CD
    Clin Dev Immunol; 2012; 2012():967584. PubMed ID: 22792121
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical significance of renal biopsies showing mixed mesangial and global proliferative lupus nephritis.
    Baumal R; Farine M; Poucell S
    Am J Kidney Dis; 1987 Sep; 10(3):236-40. PubMed ID: 3631071
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Protocol renal biopsy in patients with lupus nephritis: a single center experience.
    Singh A; Ghosh R; Kaur P; Golay V; Pandey R; Roychowdhury A
    Saudi J Kidney Dis Transpl; 2014 Jul; 25(4):801-7. PubMed ID: 24969191
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Morphologic transformation of renal lesions by steroid treatment and its therapeutic implication in a patient with lupus nephritis].
    Saito M; Nakabayashi K; Maemura C; Kitamoto K; Nagasawa T
    Ryumachi; 1990 Jun; 30(3):190-5; discussion 195-7. PubMed ID: 2244253
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Combination immunosuppressant therapy and lupus nephritis outcome: a hospital-based study.
    Chen YM; Hung WT; Liao YW; Hsu CY; Hsieh TY; Chen HH; Hsieh CW; Lin CT; Lai KL; Tang KT; Tseng CW; Huang WN; Chen YH
    Lupus; 2019 Apr; 28(5):658-666. PubMed ID: 30971165
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rituximab in lupus nephritis: A non-systematic review.
    Zurita Gavilanes L; Costa Valarezo A
    Reumatol Clin; 2016; 12(4):210-5. PubMed ID: 26906063
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Revised classification of lupus nephritis is valuable in predicting renal outcome with an indication of the proportion of glomeruli affected by chronic lesions.
    Hiramatsu N; Kuroiwa T; Ikeuchi H; Maeshima A; Kaneko Y; Hiromura K; Ueki K; Nojima Y
    Rheumatology (Oxford); 2008 May; 47(5):702-7. PubMed ID: 18390590
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The clinical relevance of repeat renal biopsies in the management of lupus nephritis: a South African experience.
    Tannor EK; Bates WD; Moosa MR
    Lupus; 2018 Apr; 27(4):525-535. PubMed ID: 28820361
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of Autoantibodies to Erythropoietin Receptor in Systemic Lupus Erythematosus with Biopsy-proven Lupus Nephritis.
    Hara A; Furuichi K; Yamahana J; Yasuda H; Iwata Y; Sakai N; Shimizu M; Kaneko S; Wada T
    J Rheumatol; 2016 Jul; 43(7):1328-34. PubMed ID: 27134248
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Late-onset biopsy-proven lupus nephritis without other associated autoimmune diseases: severity and long-term outcome.
    Ugolini-Lopes MR; Santos LPS; Stagnaro C; Seguro LPC; Mosca M; Bonfá E
    Lupus; 2019 Jan; 28(1):123-128. PubMed ID: 30442061
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy and Safety of Rituximab Therapy for Lupus Nephritis Among SLE Female Patients; a Retrospective Hospital-Based Study.
    Abdelkarim Aloub KO; Eltahirm NIA; Elagib EM; Adam Essa ME; Hussein MMA
    Open Access Rheumatol; 2022; 14():301-308. PubMed ID: 36536922
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Glomerulomegaly in lupus nephritis: a prognostic marker for renal outcomes.
    Hanaoka H; Kuwana M; Takeuchi T
    Int J Rheum Dis; 2015 Sep; 18(7):768-75. PubMed ID: 26179413
    [TBL] [Abstract][Full Text] [Related]  

  • 60. International survey on the management of patients with SLE. III. The results of a questionnaire regarding renal involvement.
    Doria A; Vitali C; Tincani A; Balestrieri G; Galeazzi M; Meroni PL; Migliorini P; Neri R; Tavoni A; Bombardieri S
    Clin Exp Rheumatol; 1996; 14 Suppl 16():S31-8. PubMed ID: 9049451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.